Clinical Trials Browser

Phase 2 × Unknown × tositumomab I-131 × Clear all

NCT00022932 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

Phase 2 Unknown

Lymphoma, Non-Hodgkin